Innovator股票定义保护主动型ETF-6个月(4月/10月) APOC 深 沪
等待开盘 04-02 09:30:00 美东时间
25.85
+0.310
+1.21%
华盛通- 最 高25.8999
- 今 开25.85
- 成交量 27.24万股
- 最 低 25.80
- 昨 收 25.54
- 总市值 7948.88万
- 52周最高 26.47
- 市盈率 静 --
- 换手率 8.86%
- 52周最低 24.84
- 委 比 -85.19%
- 总股本 307.50万
- 历史最高 26.47
- 量 比 12.32
- 振 幅 0.39%
- 历史最低 24.60
- 每 手 1
- 风险率 0.40%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多ROI-US jobs data forces gaze back from Mideast mayhem to AI 'doom': McGeever
ROI-US jobs data forces gaze back from Mideast mayhem to AI 'doom': McGeever The opinions expressed here are those of the author , a columnist for Reuters By Jamie McGeever ORLANDO, Florida, March 5 (Reuters) - With war still raging in the Middle East , investors on Friday will, at least temporarily
03-05 22:00
2026开年中国创新药BD交易刷新阶段新高 瑞博生物大涨超6%
①小核酸药物技术为何近期频繁获得国际制药巨头的高额授权合作？ ②在2026年开年创新药BD交易规模已达332.8亿美元的背景下，合作热潮是否可持续？
02-12 10:13
Arrowhead Pharmaceuticals Launches Phase 1/2a Trial of Dual-Target RNAi Therapy for Mixed Hyperlipidemia
Arrowhead Pharmaceuticals Launches Phase 1/2a Trial of Dual-Target RNAi Therapy for Mixed Hyperlipidemia Arrowhead Pharmaceuticals Inc. has announced the initiation of a Phase 1/2a clinical trial for ARO-DIMER-PA, an investigational RNA interference (RNAi) therapeutic being developed for the treatme
01-28 01:02
Arrowhead Pharmaceuticals Unveils Pipeline Progress and First Commercial Launch in Investor Presentation
Arrowhead Pharmaceuticals Inc. has released a corporate presentation highlighting its recent achievements and future plans. The company reported its first commercial launch in 2025 with REDEMPLO® (plo...
2025-12-08 10:05
